These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 33626627)
1. [Review of near real-time vaccine safety surveillance]. Sun YX; Liu ZK; Nie XL; Zhan SY Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Feb; 42(2):351-356. PubMed ID: 33626627 [TBL] [Abstract][Full Text] [Related]
2. [Develop the active surveillance system for vaccine safety in China]. Cai T; Zhan SY Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Jul; 53(7):664-667. PubMed ID: 31288335 [TBL] [Abstract][Full Text] [Related]
3. Participant-centred active surveillance of adverse events following immunisation: a narrative review. Cashman P; Macartney K; Khandaker G; King C; Gold M; Durrheim DN Int Health; 2017 May; 9(3):164-176. PubMed ID: 28582563 [TBL] [Abstract][Full Text] [Related]
4. [Scoping review of active surveillance systems for vaccine safety world-wide]. Cai T; Liu LL; Yao XY; Liu ZK; Yang Y; Meng RR; Zhan SY Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Jul; 53(7):724-730. PubMed ID: 31288345 [No Abstract] [Full Text] [Related]
5. Routine surveillance of adverse events following immunization as an important tool to monitor vaccine safety. Alicino C; Merlano C; Zappettini S; Schiaffino S; Della Luna G; Accardo C; Gasparini R; Durando P; Icardi G Hum Vaccin Immunother; 2015; 11(1):91-4. PubMed ID: 25483520 [TBL] [Abstract][Full Text] [Related]
6. Systematic review of reporting rates of adverse events following immunization: an international comparison of post-marketing surveillance programs with reference to China. Guo B; Page A; Wang H; Taylor R; McIntyre P Vaccine; 2013 Jan; 31(4):603-17. PubMed ID: 23200940 [TBL] [Abstract][Full Text] [Related]
7. Surveillance for adverse events following immunization (AEFI) for 7 years using a computerised vaccination system. Alguacil-Ramos AM; Muelas-Tirado J; Garrigues-Pelufo TM; Portero-Alonso A; Diez-Domingo J; Pastor-Villalba E; Lluch-Rodrigo JA Public Health; 2016 Jun; 135():66-74. PubMed ID: 26976484 [TBL] [Abstract][Full Text] [Related]
8. Surveillance of adverse events following the introduction of 13-valent pneumococcal conjugate vaccine in infants, and comparison with adverse events following 7-valent pneumococcal conjugate vaccine, in Victoria, Australia. Littlejohn ES; Clothier HJ; Perrett KP; Danchin M Hum Vaccin Immunother; 2015; 11(7):1828-35. PubMed ID: 26075435 [TBL] [Abstract][Full Text] [Related]
9. Post-marketing safety surveillance for inactivated and live-attenuated Japanese encephalitis vaccines in China, 2008-2013. Wu W; Liu D; Li K; Nuorti JP; Nohynek HM; Xu D; Ye J; Zheng J; Wang H Vaccine; 2017 Jun; 35(29):3666-3671. PubMed ID: 28552510 [TBL] [Abstract][Full Text] [Related]
10. Deaths reported to national surveillance for adverse events following immunization in China, 2010-2015. Wu W; Liu D; Nuorti JP; Li K; Xu D; Ye J; Zheng J; Cao L; Wang H Vaccine; 2019 Feb; 37(9):1182-1187. PubMed ID: 30709723 [TBL] [Abstract][Full Text] [Related]
11. Adverse events following immunization in Ontario's female school-based HPV program. Harris T; Williams DM; Fediurek J; Scott T; Deeks SL Vaccine; 2014 Feb; 32(9):1061-6. PubMed ID: 24440208 [TBL] [Abstract][Full Text] [Related]
15. Safety of pentavalent DTaP-IPV/Hib combination vaccine in post-marketing surveillance in Guangzhou, China, from 2011 to 2017. Li Z; Xu J; Tan H; Zhang C; Chen J; Ni L; Yun X; Huang Y; Wang W Int J Infect Dis; 2020 Oct; 99():149-155. PubMed ID: 32795602 [TBL] [Abstract][Full Text] [Related]
16. Continuous active surveillance of adverse events following immunisation using SMS technology. Westphal DW; Williams SA; Leeb A; Effler PV Vaccine; 2016 Jun; 34(29):3350-5. PubMed ID: 27206385 [TBL] [Abstract][Full Text] [Related]
17. Adverse events following immunization: is this time for the use of WHO causality assessment? Tafuri S; Gallone MS; Calabrese G; Germinario C Expert Rev Vaccines; 2015 May; 14(5):625-7. PubMed ID: 25805053 [TBL] [Abstract][Full Text] [Related]